|
|
|
Insider
Information: |
Sato Vicki L |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,670,897 |
|
Indirect Shares
|
8,084 |
|
|
Direct
Value |
$40,918,225 |
|
|
Indirect Value
|
$3,617,833 |
|
|
Total
Shares |
1,678,981 |
|
|
Total
Value |
$44,536,057 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
President |
2005-05-11 |
77,233 |
2005-05-11 |
8,084 |
Premium* |
|
Perkinelmer Inc |
PKI |
Director |
2017-02-09 |
29,970 |
2004-04-27 |
0 |
Premium* |
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2006-09-12 |
11,051 |
2006-09-12 |
0 |
Premium* |
|
Borgwarner Inc |
BWA |
Director |
2020-04-29 |
19,823 |
2014-04-30 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-15 |
116,369 |
2017-12-12 |
0 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-06-30 |
1,315,351 |
|
0 |
Premium* |
|
Allogene Therapeutics, Inc. |
ALLO |
|
2023-06-13 |
101,100 |
2021-07-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
227 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 10
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
Director |
|
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,986 |
142,149 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
|
|
2022-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
22,089 |
41,451 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-07-08 |
4 |
AS |
$28.87 |
$520,694 |
D/D |
(17,915) |
1,470,664 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-08-08 |
4 |
AS |
$30.29 |
$542,685 |
D/D |
(17,915) |
1,452,749 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-09-08 |
4 |
AS |
$21.90 |
$392,335 |
D/D |
(17,915) |
1,434,834 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-10-10 |
4 |
AS |
$20.67 |
$370,278 |
D/D |
(17,915) |
1,416,919 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-11-08 |
4 |
AS |
$27.38 |
$490,549 |
D/D |
(17,915) |
1,399,004 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2022-12-08 |
4 |
AS |
$25.81 |
$462,366 |
D/D |
(17,915) |
1,381,089 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-01-09 |
4 |
AS |
$25.83 |
$462,784 |
D/D |
(17,915) |
1,363,174 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-02-08 |
4 |
AS |
$28.35 |
$508,343 |
D/D |
(17,915) |
1,345,259 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-03-08 |
4 |
AS |
$22.59 |
$405,062 |
D/D |
(17,935) |
1,327,324 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
1,333,351 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
136,369 |
0 |
- |
|
ALLO |
Allogene Therapeutics, In... |
|
|
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
59,649 |
101,100 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-06-28 |
4 |
AS |
$29.55 |
$49,709 |
D/D |
(1,666) |
134,703 |
0 |
% |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-06-30 |
4 |
AS |
$24.66 |
$443,916 |
D/D |
(18,000) |
1,315,351 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-07-17 |
4 |
AS |
$29.60 |
$49,314 |
D/D |
(1,666) |
133,037 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-08-15 |
4 |
AS |
$24.30 |
$40,484 |
D/D |
(1,666) |
131,371 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-09-15 |
4 |
AS |
$23.60 |
$39,348 |
D/D |
(1,666) |
129,705 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-10-16 |
4 |
AS |
$20.66 |
$34,420 |
D/D |
(1,666) |
128,039 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-11-15 |
4 |
AS |
$19.13 |
$31,871 |
D/D |
(1,666) |
126,373 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-12-15 |
4 |
AS |
$23.39 |
$38,968 |
D/D |
(1,666) |
124,707 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2024-01-16 |
4 |
AS |
$18.42 |
$30,688 |
D/D |
(1,666) |
123,041 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2024-02-15 |
4 |
AS |
$18.37 |
$30,604 |
D/D |
(1,666) |
121,375 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2024-03-15 |
4 |
AS |
$20.10 |
$33,487 |
D/D |
(1,666) |
119,709 |
0 |
% |
|
227 Records found
|
|
Page 9 of 10 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|